Robotic radiotherapy market projects 12% CAGR until 2031

The market is estimated to reach $2.9b within the forecast period.

The global robotic radiotherapy market is estimated to reach $2.9b by 2031 at a compound annual growth rate (CAGR) of 12%, according to a report by InsightAce Analytic.

The report revealed that technological advancements have primarily driven the market, with robotic systems allowing highly targeted radiation therapy to minimise damage to surrounding healthy tissues and organs.

“This accuracy leads to better treatment outcomes and reduced side effects, attracting both patients and healthcare providers,” The report said.

Moreover, the rising prevalence of cancer, particularly in ageing populations has fueled demand for advanced treatment options, whilst ongoing research and development efforts are expected to propel market growth.

Meanwhile, the report mentioned that the market faces challenges, such as high initial costs, that could impede further growth.

Furthermore, ongoing pressures to demonstrate robotic radiotherapy's long-term clinical benefits and cost-effectiveness reflect the need for extensive research and evidence-gathering.